Is the Neurosurgical Treatment of Parkinson’s Disease Still Indicated?

  • J. Siegfried
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 16)


Long-term results of the medical treatment of Parkinson’s disease are somewhat disappointing despite an increased longevity and a more prolonged functional ability. The appearance of iatrogenic side-effects lead some authors to withhold levodopa until severity of symptoms really Warrants its use. In this context the place of neurosurgery is re-evaluated. With specific indications a correctly performed stereotactic operation is still the best therapy available capable of suppressing tremor, iatrogenic hyperkinesias and rigidity and must be considered when these symptoms incapacitate the functional and social life of the patient.


Neurosurgical Treatment Zona Incerta Organic Brain Syndrome Stereotactic Operation Unpleasant Side Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Cooper, I. S.: Neurosurgical treatment of the dyskinesias. Clin. Neurosurg. 24, 367–390 (1977).PubMedGoogle Scholar
  2. [2]
    Matsumoto, K., Asano, T., Bara, T., Miyamoto, T., Ohmoto, T .: Longterm follow-up results of bilateral thalamotomy for parkinsonism. Appl. Neurophysiol. 39, 257–260 (1976/77).Google Scholar
  3. [3]
    Rinne, U. K.: Recent advances in research on parkinsonism. Acta neurol. Scand. 57, Suppl. 67, 77–113 (1978).Google Scholar
  4. [4]
    Selby, G.: The influence of previous stereotactic thalamotomy on L-dopa therapy in Parkinson’s disease. Proc. Aust. Assoc. Neurol. 13, 55–60 (1976).PubMedGoogle Scholar
  5. [5]
    Siegfried, J.: Die Parkinsonsche Krankheit und ihre Behandlung, pp. 262. Wien: Springer. 1968.Google Scholar
  6. [6]
    Siegfried, J.: Deux ans d’expérience avec la L-Dopa associée à un inhibiteur de la décarboxylase. Rev. Neurol. 122, 243–248 (1970).PubMedGoogle Scholar
  7. [7]
    Siegfried, J.: The place of L-Dopa in the treatment of Parkinson’s disease. Progr. Neurol. Surg. 5, 387–405 (1973).Google Scholar
  8. [8]
    Siegfried, J. , Klaiber, R., Ziegler, W. H .: Induced abnormal movements with L-dopa and Ro 4–4602. In: L-DOPA and Parkinsonism(Barbeau, A., McDowell, F.H., eds.), pp. 114–118. Philadelphia: F.A.Davis. 1970.Google Scholar

Copyright information

© Springer-Verlag 1980

Authors and Affiliations

  • J. Siegfried
    • 1
  1. 1.Neurosurgical ClinicUniversity of Zürich School of MedicineZürichSwitzerland

Personalised recommendations